Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Total Liabilities

Latest as of June 2026: CN¥2.39 Billion CNY ≈ $349.46 Million USD

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd total liabilities. Based on the latest financial reports, Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) has total liabilities worth CN¥2.39 Billion CNY (≈ $349.46 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See 000766 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (1994–2025)

Total liabilities of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd from 1994 to 2025. This chart illustrates how Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Tonghua Golden-Horse Pharmaceutical Indu's assets to evaluate the company's liquid asset resilience ratio.

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Competitors by Total Liabilities

The table below lists competitors of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Chang Wah Technology Co Ltd TWO:6548	Taiwan	NT$13.17 Billion
Jinyu Bio-Technology Co Ltd SHG:600201	China	CN¥1.09 Billion
NOS S.G.P.S. S.A. LS:NOS	Portugal	€2.49 Billion
Hand Enterprise Solutions Co SHE:300170	China	CN¥1.08 Billion
Allegiant Travel Company NASDAQ:ALGT	USA	$4.67 Billion
Stora Enso Oyj A HE:STEAV	Finland	€9.72 Billion
Henan Dayou Energy Co Ltd SHG:600403	China	CN¥15.65 Billion
ChengDu Hi-Tech Development Co Ltd SHE:000628	China	CN¥10.29 Billion

Liability Composition Analysis (1994–2025)

This chart breaks down Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Tonghua Golden-Horse Pharmaceutical Indu.

Liquidity & Leverage Metrics

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Total Liabilities Ratios Explained

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.95	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.03	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.51	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (1994–2025)

The table below shows the annual total liabilities of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd from 1994 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥2.17 Billion ≈ $317.00 Million	-2.78%
2024-12-31	CN¥2.23 Billion ≈ $326.06 Million	+1.23%
2023-12-31	CN¥2.20 Billion ≈ $322.09 Million	-4.99%
2022-12-31	CN¥2.32 Billion ≈ $338.99 Million	+0.66%
2021-12-31	CN¥2.30 Billion ≈ $336.78 Million	-13.99%
2020-12-31	CN¥2.68 Billion ≈ $391.58 Million	+31.69%
2019-12-31	CN¥2.03 Billion ≈ $297.35 Million	+62.65%
2018-12-31	CN¥1.25 Billion ≈ $182.81 Million	-4.51%
2017-12-31	CN¥1.31 Billion ≈ $191.45 Million	+14.56%
2016-12-31	CN¥1.14 Billion ≈ $167.12 Million	-40.18%
2015-12-31	CN¥1.91 Billion ≈ $279.39 Million	+204.96%
2014-12-31	CN¥626.09 Million ≈ $91.62 Million	+27.28%
2013-12-31	CN¥491.91 Million ≈ $71.98 Million	+78.69%
2012-12-31	CN¥275.29 Million ≈ $40.28 Million	+0.95%
2011-12-31	CN¥272.69 Million ≈ $39.90 Million	-11.09%
2010-12-31	CN¥306.71 Million ≈ $44.88 Million	+7.48%
2009-12-31	CN¥285.36 Million ≈ $41.76 Million	+10.81%
2008-12-31	CN¥257.51 Million ≈ $37.68 Million	-5.51%
2007-12-31	CN¥272.53 Million ≈ $39.88 Million	-3.38%
2006-12-31	CN¥282.05 Million ≈ $41.27 Million	-73.43%
2005-12-31	CN¥1.06 Billion ≈ $155.33 Million	+0.67%
2004-12-31	CN¥1.05 Billion ≈ $154.30 Million	-7.90%
2003-12-31	CN¥1.14 Billion ≈ $167.53 Million	+10.08%
2002-12-31	CN¥1.04 Billion ≈ $152.18 Million	+4.62%
2001-12-31	CN¥994.08 Million ≈ $145.47 Million	-15.82%
2000-12-31	CN¥1.18 Billion ≈ $172.81 Million	+312.65%
1999-12-31	CN¥286.19 Million ≈ $41.88 Million	+22.30%
1998-12-31	CN¥234.01 Million ≈ $34.24 Million	+33.40%
1997-12-31	CN¥175.42 Million ≈ $25.67 Million	+8.43%
1996-12-31	CN¥161.79 Million ≈ $23.67 Million	+48.05%
1995-12-31	CN¥109.28 Million ≈ $15.99 Million	+77.17%
1994-12-31	CN¥61.68 Million ≈ $9.03 Million	--

About Tonghua Golden-Horse Pharmaceutical Industry Co Ltd

SHE:000766 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.95 Billion

CN¥13.33 Billion CNY

Market Cap Rank

#6000 Global

#1070 in China

Share Price

CN¥13.79

Change (1 day)

-3.57%

52-Week Range

CN¥13.79 - CN¥29.50

All Time High

CN¥29.50